Abstract
The story of heparanase (HPSE) in viral infection has roots in the longstanding connection between heparan sulfate (HS) and a large number of viruses. As a major viral attachment and entry receptor present on the cell surface, HS serves as the first point of contact between a virus particle and its target host cell. Likewise, direct regulation of HS levels on the cell surface by HPSE enzymatic activity dictates the extent of virus release after replication has occurred. Additionally, virus-induced HPSE activation and nuclear translocation results in higher expression of pro-inflammatory factors and delayed wound healing leading to worsened disease. In this chapter, using herpes simplex virus (HSV) as a prototype virus we provide a brief synopsis of important stages in viral infection, describe how these processes are governed by HS and HPSE, and discuss the recent discoveries that designate HPSE as a major host virulence factor and driver of pathogenesis for several different viruses.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Medeiros, G. F., Mendes, A., Castro, R. A., Bau, E. C., Nader, H. B., & Dietrich, C. P. (2000). Distribution of sulfated glycosaminoglycans in the animal kingdom: Widespread occurrence of heparin-like compounds in invertebrates. Biochimica et Biophysica Acta, 1475(3), 287–294.
Esko, J. D., & Lindahl, U. (2001). Molecular diversity of heparan sulfate. Journal of Clinical Investigation, 108(2), 169–173. https://doi.org/10.1172/jci200113530.
Shriver, Z., Capila, I., Venkataraman, G., & Sasisekharan, R. (2012). Heparin and heparan sulfate: Analyzing structure and microheterogeneity. Handbook of Experimental Pharmacology, 207, 159–176. https://doi.org/10.1007/978-3-642-23056-1_8.
Barth, H., Schafer, C., Adah, M. I., Zhang, F. M., Linhardt, R. J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., Van Kuppevelt, T. H., Depla, E., Von Weizsacker, F., Blum, H. E., & Baumert, T. F. (2003). Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. Journal of Biological Chemistry, 278(42), 41003–41012. https://doi.org/10.1074/jbc.M302267200.
Chen, Y. P., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Medicine, 3(8), 866–871. https://doi.org/10.1038/nm0897-866.
Feldman, S. A., Audet, S., & Beeler, J. A. (2000). The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. Journal of Virology, 74(14), 6442–6447. https://doi.org/10.1128/jvi.74.14.6442-6447.2000.
Giroglou, T., Florin, L., Schafer, F., Streeck, R. E., & Sapp, M. (2001). Human papillomavirus infection requires cell surface heparan sulfate. Journal of Virology, 75(3), 1565–1570. https://doi.org/10.1128/jvi.75.3.1565-1570.2001.
Roderiquez, G., Oravecz, T., Yanagishita, M., Bou-Habib, D. C., Mostowski, H., & Norcross, M. A. (1995). Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. Journal of Virology, 69(4), 2233–2239.
Shukla, D., & Spear, P. G. (2001). Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. The Journal of Clinical Investigation, 108(4), 503–510. https://doi.org/10.1172/JCI13799.
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999). A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 99(1), 13–22.
Dogra, P., Martin, E. B., Williams, A., Richardson, R. L., Foster, J. S., Hackenback, N., Kennel, S. J., Sparer, T. E., & Wall, J. S. (2015). Novel heparan sulfate-binding peptides for blocking herpesvirus entry. PLoS One, 10(5), e0126239. https://doi.org/10.1371/journal.pone.0126239.
Jaishankar, D., Yakoub, A. M., Bogdanov, A., Valyi-Nagy, T., & Shukla, D. (2015). Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: Implications for the development of entry-based antiviral therapy. Journal of Virology, 89(3), 1932–1938. https://doi.org/10.1128/JVI.02979-14.
Jaishankar, D., Buhrman, J. S., Valyi-Nagy, T., Gemeinhart, R. A., & Shukla, D. (2016). Extended release of an anti-Heparan Sulfate peptide from a contact Lens suppresses corneal herpes simplex Virus-1 infection. Investigative Ophthalmology & Visual Science, 57(1), 169–180. https://doi.org/10.1167/iovs.15-18365.
Tiwari, V., Liu, J., Valyi-Nagy, T., & Shukla, D. (2011). Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. The Journal of Biological Chemistry, 286(28), 25406–25415. https://doi.org/10.1074/jbc.M110.201103.
Oh, M. J., Akhtar, J., Desai, P., & Shukla, D. (2010). A role for heparan sulfate in viral surfing. Biochemical and Biophysical Research Communications, 391(1), 176–181. https://doi.org/10.1016/j.bbrc.2009.11.027.
O’donnell, C. D., Tiwari, V., Oh, M. J., & Shukla, D. (2006). A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology, 346(2), 452–459. https://doi.org/10.1016/j.virol.2005.11.003.
Xia, G., Chen, J., Tiwari, V., Ju, W., Li, J. P., Malmstrom, A., Shukla, D., & Liu, J. (2002). Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. The Journal of Biological Chemistry, 277(40), 37912–37919. https://doi.org/10.1074/jbc.M204209200.
Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, Shukla D. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus entry. The Journal of Cell Biology 174(7):1009–1021. PubMed PMID: 17000878; PubMed Central PMCID: PMC2064392.
Taddeo, B., & Roizman, B. (2006). The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase a. Journal of Virology, 80(18), 9341–9345. https://doi.org/10.1128/JVI.01008-06.
Cohen, S., Au, S., & Pante, N. (2011). How viruses access the nucleus. Biochimica et Biophysica Acta, 1813(9), 1634–1645. https://doi.org/10.1016/j.bbamcr.2010.12.009.
Honess, R. W., & Roizman, B. (1974). Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology, 14(1), 8–19.
Sandwall, E., Bodevin, S., Nasser, N. J., Nevo, E., Avivi, A., Vlodavsky, I., & Li, J. P. (2009). Molecular structure of heparan sulfate from Spalax. Implications of heparanase and hypoxia. The Journal of Biological Chemistry, 284(6), 3814–3822. https://doi.org/10.1074/jbc.M802196200.
Chen, G., Wang, D., Vikramadithyan, R., Yagyu, H., Saxena, U., Pillarisetti, S., & Goldberg, I. J. (2004). Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry, 43(17), 4971–4977. https://doi.org/10.1021/bi0356552.
Goldberg, R., Meirovitz, A., Hirshoren, N., Bulvik, R., Binder, A., Rubinstein, A. M., & Elkin, M. (2013). Versatile role of heparanase in inflammation. Matrix Biology, 32(5), 234–240. https://doi.org/10.1016/j.matbio.2013.02.008.
Teoh, M. L., Fitzgerald, M. P., Oberley, L. W., & Domann, F. E. (2009). Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Research, 69(15), 6355–6363. https://doi.org/10.1158/0008-5472.CAN-09-1195.
Jiao, W., Chen, Y., Song, H., Li, D., Mei, H., Yang, F., Fang, E., Wang, X., Huang, K., Zheng, L., & Tong, Q. (2018). HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. Oncogene, 37(20), 2728–2745. https://doi.org/10.1038/s41388-018-0128-0.
Wu, X., Dao Thi, V. L., Huang, Y., Billerbeck, E., Saha, D., Hoffmann, H. H., Wang, Y., Silva, L. a. V., Sarbanes, S., Sun, T., Andrus, L., Yu, Y., Quirk, C., Li, M., Macdonald, M. R., Schneider, W. M., An, X., Rosenberg, B. R., & Rice, C. M. (2018). Intrinsic immunity shapes viral resistance of stem cells. Cell, 172(3), 423–438. e25. https://doi.org/10.1016/j.cell.2017.11.018.
Meirovitz, A., Goldberg, R., Binder, A., Rubinstein, A. M., Hermano, E., & Elkin, M. (2013). Heparanase in inflammation and inflammation-associated cancer. The FEBS Journal, 280(10), 2307–2319. https://doi.org/10.1111/febs.12184.
Vlodavsky, I., & Friedmann, Y. (2001). Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. The Journal of Clinical Investigation, 108(3), 341–347. https://doi.org/10.1172/JCI13662.
Parish, C. R., Freeman, C., & Hulett, M. D. (2001). Heparanase: A key enzyme involved in cell invasion. Biochimica et Biophysica Acta, 1471(3), M99–M108.
Schonherr, E., & Hausser, H. J. (2000). Extracellular matrix and cytokines: A functional unit. Developmental Immunology, 7(2–4), 89–101.
Hadigal, S. R., Agelidis, A. M., Karasneh, G. A., Antoine, T. E., Yakoub, A. M., Ramani, V. C., Djalilian, A. R., Sanderson, R. D., & Shukla, D. (2015). Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nature Communications, 6, 6985. https://doi.org/10.1038/ncomms7985.
Hopkins, J., Yadavalli, T., Agelidis, A. M., & Shukla, D. (2018). Host enzymes Heparanase and Cathepsin L promote herpes simplex virus 2 release from cells. Journal of Virology, 92(23). https://doi.org/10.1128/JVI.01179-18.
Andela, V. B., Schwarz, E. M., Puzas, J. E., O’keefe, R. J., & Rosier, R. N. (2000). Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Research, 60(23), 6557–6562.
Cao, H. J., Fang, Y., Zhang, X., Chen, W. J., Zhou, W. P., Wang, H., Wang, L. B., & Wu, J. M. (2005). Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World Journal of Gastroenterology, 11(6), 903–907.
Wu, W., Pan, C. E., Meng, K., Zhao, L., Du, L., Liu, Q., & Lin, R. (2010). Hypoxia activates heparanase expression in an NF-kappa B dependent manner. Oncology Reports, 23(1), 255–261. https://doi.org/10.3892/or_00000631.
Air, G. M., & Laver, W. G. (1989). The neuraminidase of influenza virus. Proteins, 6(4), 341–356. https://doi.org/10.1002/prot.340060402.
Hayden, F. G., Atmar, R. L., Schilling, M., Johnson, C., Poretz, D., Paar, D., Huson, L., Ward, P., Mills, R. G., & Grp, O. S. (1999). Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. New England Journal of Medicine, 341(18), 1336–1343. https://doi.org/10.1056/Nejm199910283411802.
Guo, C., Zhu, Z., Guo, Y., Wang, X., Yu, P., Xiao, S., Chen, Y., Cao, Y., & Liu, X. (2017a). Heparanase Upregulation contributes to porcine reproductive and respiratory syndrome virus release. Journal of Virology, 91(15). https://doi.org/10.1128/JVI.00625-17.
Guo, C., Zhu, Z., Wang, X., Chen, Y., & Liu, X. (2017b). Pyrithione inhibits porcine reproductive and respiratory syndrome virus replication through interfering with NF-kappaB and heparanase. Veterinary Microbiology, 201, 231–239. https://doi.org/10.1016/j.vetmic.2017.01.033.
Khanna, M., Ranasinghe, C., Browne, A. M., Li, J. P., Vlodavsky, I., & Parish, C. R. (2019). Is host heparanase required for the rapid spread of heparan sulfate binding viruses? Virology, 529, 1–6. https://doi.org/10.1016/j.virol.2019.01.001.
Agelidis, A. M., Hadigal, S. R., Jaishankar, D., & Shukla, D. (2017). Viral activation of Heparanase drives pathogenesis of herpes simplex Virus-1. Cell Reports, 20(2), 439–450. https://doi.org/10.1016/j.celrep.2017.06.041.
Fux, L., Feibish, N., Cohen-Kaplan, V., Gingis-Velitski, S., Feld, S., Geffen, C., Vlodavsky, I., & Ilan, N. (2009). Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling. Cancer Research, 69(5), 1758–1767. https://doi.org/10.1158/0008-5472.CAN-08-1837.
Ljubimov, A. V., & Saghizadeh, M. (2015). Progress in corneal wound healing. Progress in Retinal and Eye Research, 49, 17–45. https://doi.org/10.1016/j.preteyeres.2015.07.002.
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., Myers, M. F., George, D. B., Jaenisch, T., Wint, G. R., Simmons, C. P., Scott, T. W., Farrar, J. J., & Hay, S. I. (2013). The global distribution and burden of dengue. Nature, 496(7446), 504–507. https://doi.org/10.1038/nature12060.
Puerta-Guardo, H., Glasner, D. R., & Harris, E. (2016). Dengue virus NS1 disrupts the endothelial Glycocalyx, leading to Hyperpermeability. PLoS Pathogens, 12(7), e1005738. https://doi.org/10.1371/journal.ppat.1005738.
Glasner, D. R., Ratnasiri, K., Puerta-Guardo, H., Espinosa, D. A., Beatty, P. R., & Harris, E. (2017). Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathogens, 13(11), e1006673. https://doi.org/10.1371/journal.ppat.1006673.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Agelidis, A., Shukla, D. (2020). Heparanase, Heparan Sulfate and Viral Infection. In: Vlodavsky, I., Sanderson, R., Ilan, N. (eds) Heparanase. Advances in Experimental Medicine and Biology, vol 1221. Springer, Cham. https://doi.org/10.1007/978-3-030-34521-1_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-34521-1_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34520-4
Online ISBN: 978-3-030-34521-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)